Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is… Read more
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) - Total Liabilities
Latest total liabilities as of September 2025: $1.52 Billion USD
Based on the latest financial reports, Lumexa Imaging Holdings, Inc. Common Stock (LMRI) has total liabilities worth $1.52 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lumexa Imaging Holdings, Inc. Common Stock - Total Liabilities Trend (2023–2024)
This chart illustrates how Lumexa Imaging Holdings, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lumexa Imaging Holdings, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Lumexa Imaging Holdings, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TECHTRONIC IND
MU:TIB1
|
Germany | €6.65 Billion |
|
FINLAB N (A7A.SG)
STU:A7A
|
Germany | €17.43 Million |
|
Roshni Capital Inc.
V:ROSH-P
|
Canada | CA$9.87K |
|
Nuveen California Select Tax Free Income Closed Fund
NYSE:NXC
|
USA | $795.79K |
|
KAWADA TECHNO
BE:0KT
|
Germany | €77.88 Billion |
Liability Composition Analysis (2023–2024)
This chart breaks down Lumexa Imaging Holdings, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | N/A | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.90 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lumexa Imaging Holdings, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lumexa Imaging Holdings, Inc. Common Stock (2023–2024)
The table below shows the annual total liabilities of Lumexa Imaging Holdings, Inc. Common Stock from 2023 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.51 Billion | +2.43% |
| 2023-12-31 | $1.47 Billion | -- |